Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

AstraZeneca reported $4.87B in Cash and Equivalent for its fiscal quarter ending in September of 2023.

Cash And Equivalent Change Date
Alcon AG USD 1.05B 390M Sep/2023
Almirall EUR 226.71M 21.67M Jun/2023
Amgen USD 34.74B 493M Sep/2023
Artemis Alpha GBP 978K 1.41M Jun/2022
AstraZeneca USD 4.87B 793M Sep/2023
Bayer EUR 6.82B 2.33B Sep/2023
Biogen USD 2.29B 329.9M Sep/2023
Bristol-Myers Squibb USD 7.51B 858M Sep/2023
Eli Lilly USD 2.38B 313.7M Sep/2023
Fresenius Medical Care EUR 1.27B 160.23M Dec/2022
Genmab DKK 14.27B 3.4B Sep/2023
Gilead Sciences USD 5.7B 1000K Sep/2023
GlaxoSmithKline GBP 3.18B 37M Sep/2023
GRIFOLS EUR 484.23M 39.13M Sep/2023
Haleon 490M 194M Jun/2023
Hikma Pharmaceutical USD 1000K 22M Dec/2022
Lonza CHF 1.7B 359M Jun/2023
Merck EUR 2.37B 604M Sep/2023
Orion EUR 77.9M 3.3M Sep/2023
Philips EUR 1.16B 195M Sep/2023
Recordati EUR 302.28M 226.29M Sep/2023
Regeneron Pharmaceuticals USD 2.15B 215.1M Sep/2023
Roche Holding CHF 3.72B 1.27B Jun/2023
UCB EUR 457M 442M Jun/2023